Viatris Inc (MEX:MYL) Stock News, Headlines & Updates
Viatris Inc Stock News from GuruFocus
- 1
- 2
- 3
- 4
- 5
- 6
Jul 18, 2025
Viatris Stock Slides After Phase 3 Blepharitis Drug Trial Misses Key Target
Faizan Farooque • 12:47pm
Viatris (VTRS) Shares Slide After Trial Setback for Blepharitis Treatment
GuruFocus News • 7:55am
Viatris (VTRS) Blepharitis Treatment Study Fails to Meet Primary Endpoint | VTRS Stock News
GuruFocus News • 6:18am
Viatris Inc (VTRS) Announces Phase 3 Study Results for MR-139 in Blepharitis | VTRS stock news
GuruFocus News • 6:01am
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis | VTRS Stock News
GuruFocus News • 6:00am
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
PRNewswire • 6:00am
Jun 27, 2025
Viatris' (VTRS) Phase 3 Trial Success Boosts Prospects for Eye Solution
GuruFocus News • 9:57am
Jun 26, 2025
Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia | VTRS Stock News
GuruFocus News • 6:15am
Viatris Inc (VTRS) Announces Positive Results from Phase 3 VEGA-3 Trial for Presbyopia Treatment | VTRS stock news
GuruFocus News • 6:03am
Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia
PRNewswire • 6:00am
Jun 12, 2025
Viatris Inc (VTRS) Announces Upcoming Second Quarter 2025 Financial Results | VTRS stock news
GuruFocus News • 4:02pm
Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025
PRNewswire • 4:00pm
Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 | VTRS Stock News
GuruFocus News • 3:46pm
Is Viatris Inc (VTRS) Set to Underperform? Analyzing the Factors Limiting Growth
GuruFocus News • 10:01am
Jun 10, 2025
Kuehn Law Encourages Investors of Viatris Inc. to Contact Law Firm
Marketwired • 10:00am
Jun 06, 2025
Goldman Sachs Initiates Coverage on Viatris (VTRS) with Neutral Rating | VTRS Stock News
GuruFocus News • 10:34am
Goldman Sachs Begins Coverage of Viatris (VTRS) with Neutral Rating | VTRS Stock News
GuruFocus News • 3:45am
Jun 04, 2025
VTRS Set for Key Meeting in Toronto | VTRS Stock News
GuruFocus News • 4:45pm
June 3, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against VTRS
Marketwired • 12:00pm
Jun 03, 2025
Viatris Deadline Today: Rosen Law Firm Urges Viatris Inc. (NASDAQ: VTRS) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
Business Wire • 1:00pm
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
Business Wire • 1:00pm
DEADLINE ALERT for VTRS and CGC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 11:00am
Jun 02, 2025
Viatris (VTRS) Reports Positive Phase 3 Trial Results for Night Driving Treatment
GuruFocus News • 3:58pm
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Marketwired • 3:00pm
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
Marketwired • 1:00pm
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PRNewswire • 12:00pm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
Marketwired • 11:00am
Viatris Inc (VTRS)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus News • 10:03am
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
PRNewswire • 9:00am
DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025
PRNewswire • 9:00am
Viatris Inc (VTRS) Announces Positive Phase 3 Trial Results for MR-142 | VTRS stock news
GuruFocus News • 8:13am
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
PRNewswire • 8:00am
VTRS STOCK DEADLINE TOMORROW: Suffer Losses on Viatris Inc.? BFA Law Notifies Investors of Imminent June 3 Securities Class Action Deadline (NASDAQ:VTRS)
Marketwired • 8:00am
Viatris (VTRS) Reports Positive Results from LYNX-2 Trial for Eye Treatment | VTRS Stock News
GuruFocus News • 7:48am
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions | VTRS Stock News
GuruFocus News • 7:18am
Jun 01, 2025
Viatris Deadline: VTRS Investors with Losses in Excess of $100K Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
PRNewswire • 2:00pm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
PRNewswire • 10:00am
May 31, 2025
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
PRNewswire • 8:00am
May 30, 2025
- 1
- 2
- 3
- 4
- 5
- 6
Show
Entries
Headlines
Total 0- 1
No recent news